EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges

Amol Tatode, Tanvi Premchandani, Anis Ahmad Chaudhary, Mohamed A M Ali, Mohammad Qutub, Jayshree Taksande, Rahmuddin Khan, Ujban Md Hussain, Milind Umekar

Molecular Biology Reports · 2026

DOI: 10.1007/s11033-026-11526-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Amol Tatode und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, 441002, Maharashtra, India. Hauptthemen laut MEDLINE: Exosomes, Tumor Microenvironment, Glioblastoma, Brain Neoplasms. Die Arbeit nennt 86 Literaturangaben. Gefördert von: Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) leverages exosomes to drive tumor progression, immunosuppression, and therapy resistance through transfer of oncogenic miRNAs, circRNAs, and proteins. These vesicles reprogram the tumor microenvironment (TME) by activating pathways such as TREM1 in microglia and STAT3-mediated vasculogenic mimicry. Exosomal nucleic acids, including circZNF800 and miR-374b-3p, serve as non-invasive biomarkers for recurrence and treatment monitoring. Advances in engineering, such as Angiopep-2-functionalized exosomes for blood-brain barrier penetration and CRISPR-Cas9-loaded vesicles targeting resistance genes, highlight their therapeutic potential. Challenges in heterogeneity, standardization, and scalable production underscore the need for interdisciplinary innovation to translate exosome-based strategies into clinical practice.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExosomesTumor MicroenvironmentGlioblastomaBrain NeoplasmsHumansAnimalsMicroRNAsBiomarkers, Tumor

Stichwörter der Autor:innen

BiomarkersExosomesGlioblastomaTherapeutic engineeringTumor microenvironment

Substanzen

MicroRNAsBiomarkers, Tumor

Autor:innen und Institutionen

  • Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, 441002, Maharashtra, India.
  • Department of Biology, College of Science, Mohammad Ibn Saud Islamic University (IMSIU), Imam, Riyadh, Saudi Arabia. aachaudhary@imamu.edu.sa.
  • Department of Biology, College of Science, Mohammad Ibn Saud Islamic University (IMSIU), Imam, Riyadh, Saudi Arabia.
  • Department of Pharmaceutics, Smt. Kishoritai Bhoyar College of Pharmacy, Kamptee, Nagpur, 441002, Maharashtra, India. qutubmalikqm@gmail.com.
  • Department of Pharmaceutics, School of Pharmaceutical Education & Research (SPER), Jamia Hamdard, New Delhi, 110062, India.
  • Department of Pharmaceutical Sciences, Rashtrasant Tukdoji Maharaj Nagpur University, Nagpur, Maharashtra, India.

Förderung

  • Deanship of Scientific Research at Imam Mohammad Ibn Saud Islamic University (IMSIU)

Zitieren

APA

Tatode, A., Premchandani, T., Chaudhary, A. A., Ali, M. A. M., Qutub, M., Taksande, J., Khan, R., Hussain, U. M., & Umekar, M. (2026). Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-11526-2

Vancouver

Tatode A, Premchandani T, Chaudhary AA, Ali MAM, Qutub M, Taksande J, et al. Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-11526-2

BibTeX
@article{Tatode2026,
  author = {Tatode, Amol and Premchandani, Tanvi and Chaudhary, Anis Ahmad and Ali, Mohamed A M and Qutub, Mohammad and Taksande, Jayshree and Khan, Rahmuddin and Hussain, Ujban Md and Umekar, Milind},
  title = {Glioblastoma exosomes reprogramming the tumor microenvironment and evading therapeutic challenges},
  journal = {Molecular Biology Reports},
  year = {2026},
  doi = {10.1007/s11033-026-11526-2}
}
Kostenlos starten →